首頁 > 市場調查報告書 > 製藥

奈米技術 DDS

市場調查報告書

商品編碼

1651702

奈米醫藥市場規模、佔有率和成長分析（按產品類型、應用、適應症、方式和地區）- 產業預測 2025-2032

Nanomedicine Market Size, Share, and Growth Analysis, By Product Type (Nano Molecules, Nanoparticles), By Application (Vaccines, Regenerative Medicines), By Indication, By Modality, By Region - Industry Forecast 2025-2032

出版日期: 2025年02月06日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2023 年奈米醫藥市場規模將達到 1,994 億美元，從 2024 年的 2,241.3 億美元成長到 2032 年的 5,709.8 億美元，預測期內（2025-2032 年）的複合年成長率為 12.4%。

由於專注於開發創新解決方案來滿足未滿足的醫療需求並改善患者治療效果，奈米醫藥市場預計將經歷顯著成長。奈米醫學具有改善藥物傳輸、生物有效性和標靶治療等優點，利用先進的奈米技術實現更精確和個人化的治療。促進因素包括奈米技術的進步，這些進步使得新的醫療應用成為可能，但需要克服諸如高開發成本和擴大生產規模的複雜性等挑戰。儘管存在這些障礙，但隨著慢性病盛行率的上升，這個市場仍有大量機會，特別是在有針對性的藥物傳輸系統和診斷領域。總體而言，美國奈米醫藥市場預計將經歷持續成長，並透過創新解決方案改變醫療保健服務。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前 5 家公司對比
主要企業市場定位（2024年）
主要市場參與者所採用的策略
近期市場趨勢
公司市場佔有率分析（2024 年）
主要企業簡介
- 公司詳細資訊
- 產品系列分析
- 公司分部佔有率分析
- 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

Imina Technologies SA（Switzerland）
NANONICS IMAGING Ltd.（US）
Altair Nanotechnologies Inc.（US）
Bruker Corporation（US）
Kleindiek Nanotechnik GmbH（Germany）
eSpin Technologies, Inc.（US）
Advanced Nano Products Co., Ltd.（South Korea）
Applied Nanotech, Inc.（US）
Biosensors International Group, Ltd.（Singapore）
Thermo Fisher Scientific Inc.（US）
BASF（Germany）
Nanotech Energy（US）
Advanced Test Equipment Corporation（US）
Werfen（Spain）
SomaLogic（US）
Palamedrix（US）
NaNotics LLC（US）
Innovasis, Inc.（US）
Promimic（US）

結論和建議

簡介目錄

Product Code: SQMIG35I2200

Nanomedicine Market size was valued at USD 199.4 billion in 2023 and is poised to grow from USD 224.13 billion in 2024 to USD 570.98 billion by 2032, growing at a CAGR of 12.4% during the forecast period (2025-2032).

The nanomedicine market is poised for significant growth as it focuses on developing innovative solutions that address unmet medical needs and enhance patient outcomes. With advantages such as improved drug delivery, bioavailability, and targeted therapies, nanomedicine leverages advanced nanotechnology to create more precise and personalized treatments. Driving factors include advancements in nanotechnology, which enable novel medical applications, while challenges like high development costs and the complexity of scaling up production must be navigated. Despite these hurdles, the market offers ample opportunities, especially in targeted drug delivery systems and diagnostics amidst the rising prevalence of chronic diseases. Overall, the US nanomedicine market is expected to experience sustainable growth, transforming healthcare delivery through innovative solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Nanomedicine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Nanomedicine Market Segments Analysis

Global Nanomedicine Market is segmented by Product Type, Application, Indication, Modality and region. Based on Product Type, the market is segmented into Nano Molecules, Nanoparticles, Liposomes, Polymer and Polymer Drug Conjugates, Hydrogel Nanoparticles, Dendrimers, Nanoshells, Nanotubes and Nanodevices. Based on Application, the market is segmented into Vaccines, Regenerative Medicines, Diagnostic Imaging, Drug Delivery, Implants, In-Vitro Imaging,in-vitro diagnostics, Therapeutics and Others. Based on Indication, the market is segmented into Oncological Diseases, Infectious Diseases, Cardiovascular Diseases, Orthopedic Disorders, Neurological Disorders, Urological Disorders, Ophthalmological Diseases, Immunological Diseases, Anti-Inflammatory Diseases, Anti-Infective Diseases and Others. Based on Modality, the market is segmented into Treatment and Diagnostics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Nanomedicine Market

The increasing prevalence of chronic illnesses like cancer, cardiovascular diseases, and diabetes significantly propels the growth of the nanomedicine market. This innovative field provides targeted and personalized treatment solutions that not only enhance therapeutic effectiveness but also contribute to better overall patient well-being. By leveraging nanotechnology, healthcare professionals can design treatments that specifically address individual patient needs, leading to more precise interventions. As the demand for advanced medical solutions continues to rise, the role of nanomedicine in improving health outcomes becomes increasingly vital, positioning it as a crucial market driver in the evolving landscape of modern medicine.

Restraints in the Nanomedicine Market

The nanomedicine market faces notable challenges due to the substantial research and development expenses associated with creating and commercializing these products. The intricate manufacturing processes combined with stringent regulatory requirements result in elevated costs that can impede the broader acceptance and adoption of nanomedicine solutions. Consequently, these financial barriers may deter potential investors and limit the number of products that successfully transition from the research phase to market availability, ultimately slowing down advancements in the field and restricting the potential benefits that nanomedicine could bring to healthcare.

Market Trends of the Nanomedicine Market

The nanomedicine market is experiencing significant growth, propelled by the shift towards personalized medicine. By harnessing nanotechnology, healthcare providers can develop targeted therapies that cater to individual patient profiles, optimizing efficacy and minimizing side effects. This trend is becoming increasingly prevalent as advancements in nanotechnology enable precise drug delivery systems, improved diagnostics, and tailored therapies based on genetic and molecular biomarkers. As healthcare systems focus on patient-centric care, the integration of personalized approaches through nanomedicine is set to drive market expansion, fostering innovations and the development of therapeutics that are customized to enhance treatment outcomes in diverse medical conditions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Nanomedicine Market Size by Product Type & CAGR (2025-2032)

Market Overview
Nano Molecules
Nanoparticles
Liposomes
Polymer and Polymer Drug Conjugates
Hydrogel Nanoparticles
Dendrimers
Nanoshells
Nanotubes
Nanodevices

Global Nanomedicine Market Size by Application & CAGR (2025-2032)

Market Overview
Vaccines
Regenerative Medicines
Diagnostic Imaging
Drug Delivery
Implants
In-Vitro Imaging
In-Vitro Diagnostics
Therapeutics
Others

Global Nanomedicine Market Size by Indication & CAGR (2025-2032)

Market Overview
Oncological Diseases
Infectious Diseases
Cardiovascular Diseases
Orthopedic Disorders
Neurological Disorders
Urological Disorders
Ophthalmological Diseases
Immunological Diseases
Anti-Inflammatory Diseases
Anti-Infective Diseases
Others

Global Nanomedicine Market Size by Modality & CAGR (2025-2032)

Market Overview
Treatment
Diagnostics

Global Nanomedicine Market Size & CAGR (2025-2032)

North America (Product Type, Application, Indication, Modality)
- US
- Canada
Europe (Product Type, Application, Indication, Modality)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Application, Indication, Modality)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Application, Indication, Modality)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Application, Indication, Modality)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Imina Technologies SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NANONICS IMAGING Ltd. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Altair Nanotechnologies Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Corporation (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kleindiek Nanotechnik GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
eSpin Technologies, Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Advanced Nano Products Co., Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Applied Nanotech, Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biosensors International Group, Ltd. (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BASF (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nanotech Energy (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Advanced Test Equipment Corporation (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Werfen (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SomaLogic (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Palamedrix (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NaNotics LLC (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Innovasis, Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promimic (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments